Cargando…

Precision Medicine to Treat Urothelial Carcinoma—The Way Forward

SIMPLE SUMMARY: The treatment of urothelial carcinoma is challenging. While known therapies are effective, the results can be variable. Known treatment modalities include transurethral resection of the bladder tumor, intravesicular BCG, chemotherapy, immune check point inhibitors, and antibody drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luceno, Carvy Floyd, Jeon, Won Jin, Samaeekia, Ravand, Shin, John, Sonpavde, Guru P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252480/ https://www.ncbi.nlm.nih.gov/pubmed/37296985 http://dx.doi.org/10.3390/cancers15113024

Ejemplares similares

The microbiome in precision medicine: the way forward
por: Petrosino, Joseph F.
Publicado: (2018)

Chemosis as an Initial Presentation of Systemic Lupus Erythematosus
por: Luceno, Carvy Floyd, et al.
Publicado: (2022)

Pharmacogenomics based precision medicine in gastroesophageal cancers: way to move forward?
por: Shah, Shrunjal, et al.
Publicado: (2020)

Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma(1)
por: Leiter, Amanda, et al.
Publicado: (2016)

Precise treatments for schizophrenia: where is the way forward?
por: Zhang, Chen, et al.
Publicado: (2018)

Utility of Handheld Ultrasound Performed by Cardiology Fellows in Patients Presenting with Suspected ST-Elevation Myocardial Infarction
por: Samaeekia, Ravand, et al.
Publicado: (2022)

ALTERNATIVE MEDICINE: WHICH WAY FORWARD?
por: Al-Dawood, Kasim M.
Publicado: (2000)

Community Medicine in India — Which Way Forward?
por: Krishnan, Anand
Publicado: (2016)

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
por: Grivas, Petros, et al.
Publicado: (2018)

The Way Forward Is the Way Back
por: Potter, Polyxeni
Publicado: (2007)

Activating the Intrinsic Pathway of Apoptosis Using BIM BH3 Peptides Delivered by Peptide Amphiphiles with Endosomal Release
por: Schnorenberg, Mathew R., et al.
Publicado: (2019)

The way forward
Publicado: (2002)

The Way Forward
por: Singh, Yamuna
Publicado: (2020)

The Way Forward
Publicado: (2005)

Rational use of medicines: Cost consideration & way forward
por: Kshirsagar, Nilima A.
Publicado: (2016)

Grading of invasive breast carcinoma: the way forward
por: van Dooijeweert, C., et al.
Publicado: (2021)

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors
por: Nuzzo, Pier Vitale, et al.
Publicado: (2020)

FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma
por: Adib, Elio, et al.
Publicado: (2021)

Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing
por: Samaeekia, Ravand, et al.
Publicado: (2018)

The International Society for Complementary Medicine Research (ISCMR): the Way Forward
por: Lewith, George T, et al.
Publicado: (2006)

Which Way Forward
por: Colfer, Carol
Publicado: (2010)

Endocrinology: The Way Forward
por: Chadha, Manoj
Publicado: (2018)

New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib
por: Cowey, C Lance, et al.
Publicado: (2010)

Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting
por: Bakker, Elisabeth, et al.
Publicado: (2021)

In Vivo Biomarker Imaging: Paving the Way for Precision Medicine
por: Liu, Guanshu, et al.
Publicado: (2023)

Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2015)

Precision oncology in urothelial cancer
por: Liow, Elizabeth, et al.
Publicado: (2020)

25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward
por: Dean, Anna S, et al.
Publicado: (2022)

Herd immunity: challenges and the way forward in Korea
por: Oh, Jiyoung, et al.
Publicado: (2021)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach
por: Sarkar, Suryadipto, et al.
Publicado: (2023)

Metastatic medullary thyroid carcinoma: a new way forward
por: Angelousi, Anna, et al.
Publicado: (2022)

Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma
por: Ferrante, Giuliana, et al.
Publicado: (2022)

Forward Precision Medicine: Micelles for Active Targeting Driven by Peptides
por: Prencipe, Filippo, et al.
Publicado: (2021)

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
por: Nassar, Amin H., et al.
Publicado: (2019)

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma
por: Jun, Tomi, et al.
Publicado: (2022)

Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016)

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
por: Gourdin, Theodore, et al.
Publicado: (2018)

Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
por: Thomas, Jonathan, et al.
Publicado: (2022)

The three Rs: the way forward.
por: Zurlo, J, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_njefd5o6ag69kr064k1i7gk8e6